C. Tinchon

发表

Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies

A. Tiran, H. Auner, F. Quehenberger, 2003, Annals of Hematology.

predisposes to high-risk myelodysplastic syndrome A functional single nucleotide polymorphism of the G-CSF receptor gene

W. Renner, M. Pfeilstöcker, S. Erkeland, 2012 .

Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis.

Song-Cheol Kim, M. McCarter, P. Parikh, 2019, Journal of the National Cancer Institute.

Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis.

J. Lacy, N. Jamieson, M. Katz, 2018, Journal of the National Cancer Institute.

Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high‐dose cyclophosphamide

R. Brezinschek, A. Tiran, H. Auner, 2002, European journal of haematology.

Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.

A. Berghold, R. Greil, F. Keil, 2013, European journal of cancer.

Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma

M. Pichler, T. Bauernhofer, F. Keil, 2013, Acta oncologica.

Neoadjuvant FOLFIRINOX in pancreatic cancer 1231

M. Pichler, T. Bauernhofer, G. Leitner, 2013 .

Correspondence re: O. J. Arola et al., acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res., 60: 1789-1792, 2000.

H. Auner, H. Sill, W. Linkesch, 2001, Cancer research.

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

R. Greil, C. Schmitt, C. Singer, 2021, Breast Cancer Research.

Clinical-Pathological Conference Series from the Medical University of Graz

C. Langner, G. Krejs, E. Fabian, 2020, Wiener klinische Wochenschrift.

Concomitant immune thrombocytopenia and bone marrow hemophagocytosis in a patient with SARS-CoV-2

S. Michaelis, D. Enko, C. Tinchon, 2021, Clinical chemistry and laboratory medicine.

A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting

R. Greil, S. Schmidt, P. Valent, 2020, Wiener klinische Wochenschrift.

Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents—A Prospective Cohort Study of the AGMT Study-Group

L. Pleyer, R. Greil, S. Machherndl-Spandl, 2022, Cancers.

Troponins in prediction of cardiotoxic effects

H. Auner, F. Quehenberger, H. Sill, 2001, The Lancet.

Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes

L. Pleyer, R. Greil, P. Krippl, 2014 .

Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry

L. Pleyer, R. Greil, P. Krippl, 2014 .

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

L. Pleyer, R. Greil, P. Krippl, 2013, Journal of Hematology & Oncology.

Symptomatic Epstein–Barr virus reactivation in a patient with acute myeloid leukaemia and treatment with the monoclonal anti‐CD20 antibody rituximab

H. Auner, H. Sill, W. Linkesch, 2002, European journal of haematology.

The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS)

J. Szkandera, T. Brodowicz, F. Ploner, 2013, Journal of Cancer Research and Clinical Oncology.

A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome.

W. Renner, M. Pfeilstöcker, S. Erkeland, 2005, Blood.

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34

R. Greil, M. Gnant, Z. Bago-Horvath, 2021, British Journal of Cancer.

Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.

M. Mitterberger, T. Bauernhofer, M. Kretz, 2019, Clinical genitourinary cancer.

Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2− advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT

R. Greil, M. Gnant, G. Steger, 2020, Breast.

Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34

R. Greil, M. Gnant, P. Regitnig, 2018 .

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

L. Pleyer, R. Greil, P. Krippl, 2014, Annals of Hematology.

L. Pleyer, R. Greil, J. Hasenauer, 2023, Cancers.

Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group

L. Pleyer, R. Greil, C. Schmitt, 2019, Blood.

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

F. Bertucci, S. Linn, F. Puglisi, 2022, ESMO open.

283P Treatment landscape of HER2-positive metastatic breast cancer (MBC): Results from the Austrian AGMT_MBC-Registry

R. Greil, C. Singer, M. Knauer, 2021, Annals of Oncology.

Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).

R. Greil, M. Gnant, Z. Bago-Horvath, 2020, European journal of cancer.

Early cerebrospinal fluid infiltration in TP53-mutated blastic plasmacytoid dendritic cell neoplasm

C. Beham‐Schmid, S. Michaelis, D. Enko, 2022, Annals of Hematology.

Abstract P6-10-01: Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)

R. Greil, Z. Bago-Horvath, P. Dubsky, 2017 .

177P Low HER2 expression does not influence prognosis in metastatic triple-negative breast cancer: Results from an international, multicenter analysis coordinated by the Austrian Group Medical Tumor Therapy (AGMT)

F. Bertucci, R. Greil, M. Lambertini, 2022, Annals of Oncology.

Peripheral Blood Complete Remission Provides Added Value to the Classical Definition of Morphologic Complete Remission - a Prospective Cohort Study of 1441 Patients with MDS, CMML and AML Treated within the Austrian Azacitidine Registry

L. Pleyer, R. Greil, C. Schmitt, 2021, Blood.

Cox Proportional Hazards Deep Neural Network Identifies Peripheral Blood Complete Remission (PB-CR) to be at Least Equivalent to Morphologic CR in Predicting Outcomes of Patients Treated with Azacitidine - a Prospective Cohort Study By the AGMT

L. Pleyer, R. Greil, J. Hasenauer, 2022, Blood.